Lucid Diagnostics
NASDAQ: LUCDLake Forest, US · Delaware corporation · 1 known investors
Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.
Founders & leadership
MA
Michael A GordonExecutive Officer
SO
Shaun O'NeilExecutive Officer
LA
Lishan AklogChairman & CEO
DM
Dennis McGrathExecutive Officer
DW
Debra WhiteDirector
SL
Stanley LapidusDirector
BD
Brian deGuzmanChief Technology Officer & Chief Compliance Officer
DA
DENNIS A. MATHEISDirector
RM
Ronald M SparksDirector
DJ
DEBRA J. WHITEDirector
SN
STANLEY N. LAPIDUSDirector
JL
James L CoxDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$21.9MraisedDec 2024 · 7 investors · BiotechnologyRule 506(b)
▶$21.9MraisedDec 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL A. GORDONExecutive Officer
- DENNIS A. MATHEISDirector
- SHAUN O'NEILExecutive Officer
- RONALD M. SPARKSDirector
- LISHAN AKLOGExecutive Officer, Director
- DEBRA J. WHITEDirector
- STANLEY N. LAPIDUSDirector
- DENNIS M. MCGRATHExecutive Officer
- JAMES L. COXDirector
- JACQUE J. SOKOLOVDirector
- Offering amount
- $21.9M
- Amount sold
- $21.9M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2023 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedNov 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanley LapidusDirector
- Michael A GordonExecutive Officer
- Jacque J SokolovDirector
- Dennis McGrathExecutive Officer
- Shaun O'NeilExecutive Officer
- James L CoxDirector
- Ronald M SparksDirector
- Debra WhiteDirector
- Lishan AklogExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $250K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$11.1MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Debra WhiteDirector
- James L CoxDirector
- Shaun O'NeilExecutive Officer
- Michael A GordonExecutive Officer
- Ronald M SparksDirector
- Dennis McGrathExecutive Officer
- Jacque J SokolovDirector
- Lishan AklogExecutive Officer, Director
- Stanley LapidusDirector
- Offering amount
- $11.1M
- Amount sold
- $11.1M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$13.6MraisedMar 2023 · 4 investors · BiotechnologyRule 506(b)
▶$13.6MraisedMar 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shaun O'NeilExecutive Officer
- Ronald M SparksDirector
- Debra WhiteDirector
- Dennis McGrathExecutive Officer
- Lishan AklogExecutive Officer, Director
- Jacque J SokolovDirector
- Stanley LapidusDirector
- Michael A GordonExecutive Officer
- James L CoxDirector
- Offering amount
- $20M
- Amount sold
- $13.6M
- Minimum investment
- $250K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.